m
Recent Posts
Connect with:
Tuesday / May 21.

Cationorm

Cationorm (cationic nanoemulsion) is a preservative-free, hydrating, and lubricating emulsion eye drop that protects the eye surface, relieving the discomfort and irritation of persistent dry eye caused by prolonged use of contact lenses, or environmental conditions.1

Its triple action repairs the lipid layer to reduce evaporation by lubricating and stabilising the tear film and restores the moisture balance in the muco-aqueous layer of the tear film. It also forms a barrier to lock in moisture, giving dry eyes the time they need to heal.2,3,4,5

Administered as one drop, up to four-times daily in the affected eye, Cationorm is suitable for use with contact lenses,6  and gentle enough to use every day.7 Visit: cationorm.com.au.

Contact: CSL Seqirus (AUS) 1800 642 865  

PBS information: Cationorm Multi Dose (10 mL). Authority Required (streamlined) 6172.

Refer to PBS Schedule for full authority information. Cationorm (30 x 0.4 mL) is not listed on the PBS. Contact CSL Seqirus Medical Information on (AUS) 1800 642 865 for more information. Seqirus (Australia) Pty Ltd, Melbourne, Australia. Date of preparation: February 2024. AU-Cati-24-0007.

References

  1. Therapeutic Goods Administration. Australian Register of Therapeutic Goods – Public Summary Seqirus Pty Ltd – Lubricant, eye. [cited 2021]; Available from: ebs.tga.gov. au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=406945E40B6D2CA4CA25843C0042145B&agid=(PrintDetailsPublic)&actionid=1.
  2. Lallemand, F., et al., Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv, 2012: p. p. 604204.
  3. Daull, P., Lallemand, F., Garrigue, J.S., Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. J Pharm Pharmacol, 2014. 66(4): p. 531-41.
  4. Amrane, M., et al., Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease – a randomised comparative study. J Fr Ophtalmol, 2014. 37(8): p. 589-98.
  5. Robert, P.Y., et al., Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Eur J Ophthalmol, 2016. 26(6): p. 546-555.
  6. Cationorm product package.
  7. Cationorm: More than relief. Available from cationorm.com.au